Skip to main content

#PreventiveNeurology: is life a sexually transmitted neurodegenerative disease?

Age is a disease vs. Ageing as a natural biological process: have your say #PreventiveNeurology #HealthyAgeing

I have always cracked the joke 'that life is a sexually transmitted neurodegenerative disease with a 100% mortality'. This usually gets a mutated laugh until people start pondering the implications of the joke and realise that I am being serious.




Evolution never designed, and selected, the human brain and nervous system to function much past 35 years of age. It is only relatively recently that life expectancy has increased with the requirement of our brains to function into old age. It is clear that when we measure cognitive function, and brain volume, it is all downhill from about 35 years of age. Those of us who are older than 35 notice the subtle cognitive impairments that increase with age and the gradual malfunction of our nervous systems. When last have you tried tight-rope walking? Your failing balance system is simply a reflection of the global rot that is also shredding your cognition. Fortunately we have enough reserve to adapt and cope with slow decline in our mental faculties. However, if we live long enough we are all likely to become demented. Dementia in this setting is simply the reduction of cognition to a point when you can't manage socially and need help. To prevent the inevitable consequence of ageing is there anything we can do to optimise our brain health so our 'brains outlive' our bodies. 

How to optimise brain health so that we die of a systemic disease with our cognition relatively intact is the aim of our #PreventiveNeurology campaign. Maybe we should call it #HealthyAgeing? We have hypothesised, based on scientific principles, that there is a lot we can do to improve brain health. However, some of the interventions may require the administration of medications. For this to happen and be adopted by society we need to make ageing a disease. By defining ageing as a disease it changes everything. Firstly, it creates the incentives for the pharmaceutical industry to invest in the necessary R&D to get drugs to market. If ageing is a disease healthcare systems will pay for interventions. The corollary is that if ageing is not defined as a disease any interventions, to delay or modify ageing, will be limited to lifestyle interventions. By defining ageing as a disease it will allow us to develop tools for population screening to identify people who are either healthy or in the presymptomatic phase of known neurodegenerative disease. This will then allow us to test preventive strategies to delay the onset of symptomatic disease. 


This is why we want to shift the 'defining of ageing as a disease' debate centre stage! Please have your say. 

Comments

  1. Interesting take on things. I am prepared to have a disease called life if it leads to an improvement in my quality of life. I am interested to know what are your drug targets.

    ReplyDelete
    Replies
    1. Re: 'Drug targets'. At moment is based on reducing your cardiovascular risk, therefore antihypertensives, statins and aspirin. This is not rocket science.

      Delete
  2. Aging is not a disease. To define aging as a disease may help in the development of medications - that does not mean the definition is accurate.

    Perhaps we need to rethink our lives and life stages, and not extend life spans so much. This means we should start thinking of putting our houses in order at a younger age and be ready to let go

    ReplyDelete

Post a Comment

Popular posts from this blog

Moved to substack

Dear Reader We have moved the preventive neurology unit blog to a new platform called substack . Google is discontinuing its Feedburner and has not added many new features to blogger for some time, which is why we have decided to move the site.  https://preventiveneurology.substack.com/  Thanks Gavin Giovannoni

Are you ready for an EBV vaccine to prevent MS?

"Professor Giovannoni, you tell me that my daughter has a 1 in 40 chance of developing multiple sclerosis and that MS has reached epidemic proportions in parts of the world? Is there anything I can do to reduce her chances of getting MS? Is there anything we can do to stop other people from getting MS?" Although multiple sclerosis (MS) is a complex disease due to the interaction of genetic and environmental factors data on the occurrence of MS at the population level (epidemiology) supports the Epstein Barr Virus (EBV) as being necessary, but not sufficient, for someone to develop MS. In other words, EBV is probably the cause of MS. Of all the putative causative agents that have been proposed to be associated with MS, EBV is the only one where the risk of getting MS if you are EBV negative is close to zero or zero if you limit the analyses to those studies which use a technique called immunofluorescence microscopy as the gold-standard assay to detect anti-EBV antibodies. EBV

The Aducanumab shitstorm

Congratulations to  Al Sandrock , from Biogen, for never giving up on science and for being a  risk-taker extraordinaire .   Photo by Markus Winkler on Unsplash The FDA’s controversial approval of aducanumab for the treatment of Alzheimer’s disease on Monday has caused a shitstorm. The main reason is that in November the FDA’s independent advisory committee voted against recommending approval; they said the data failed to demonstrate persuasively that aducanumab slowed cognitive decline. In a NY Times article Dr Lon Schneider, director of the California Alzheimer’s Disease Center at the University of Southern California and one of the aducanumab site investigators said “This should not be approved, because substantial evidence of effectiveness hasn’t been shown and there’s very little potential that this will address the needs of patients.” What the FDA has done is use the so-called Accelerated Approval Pathway , which allows them to approve a drug for a serious or life-threatening